Quotient is a commercial-stage diagnostics company. Co. focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. Co. is developing MosaiQ for immunohematology (blood grouping), serological disease screening, and molecular disease screening. Co.'s reagent products, which are branded as Alba by Quotient, are used primarily to identify blood group antigens and antibodies in donor and patient blood and to perform testing for third-party blood grouping instrument platforms. Co. also undertakes product development projects for its original equipment manufacturer customers.
|
Free QTNT Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: QTNT Stock Forecast Based on Zacks ABR data; powered by Xignite |